Get CO Highline Vision Center Ilux Treatment Of Dry Eye 2018-2024

iLUX®: Dry Eye Treatment That Starts At The Source A medical professional will be at your side every step of the way, providing real-time feedback. Treatment of both eyes takes approximately 8 to12 minutes.

How effective is it? The iLUX® device has been shown to significantly reduce dry eye symptoms such as gritty eyes and irritation. In a clinical study, patients' meibomian gland scores were three times better at two weeks post-treatment and four times better at four weeks, compared to baseline.

Treatment with the iLUX® device was shown to significantly reduce dry eye symptoms such as gritty eyes and irritation. 6 In clinical studies, iLUX® was shown to increase meibomian gland function by 300% at 4 weeks post-treatment, compared to baseline.

Please note that iLux treatment is a premium service that is not covered by medical insurance. The cost for services range $325-500/ session ( usually averaging 2 sessions /year ). Call us today with any questions or to make your appointment for your consultation with Dr Kerline Marcelin or our medical associates.

Not only is iLux technology safe to use for the diagnosis and treatment of MGD, but the tear film breakup time has been found to improve by more than 50% within the first two weeks of treatment and up to 80% or higher four weeks from the date of treatment.

Please note that iLux treatment is a premium service that is not covered by medical insurance. The cost for services range $325-500/ session ( usually averaging 2 sessions /year ). Call us today with any questions or to make your appointment for your consultation with Dr Kerline Marcelin or our medical associates.

Other side-effects include eyelid and eye irritation or inflammation, temporary reddening of the skin, and other eye symptoms like burning, stinging, tearing, itching, discharge, redness, feeling like there is something in the eye, changes in your vision, and sensitivity to light.

New Dry Eye Treatments on the Horizon Several new dry eye treatments were approved by the FDA in 2023, including Miebo™ (NOV03), VEVYE™ (CyclASol), and Reproxalap. XDEMVY™ (TP-03) is another 2023 ophthalmic solution and a revolutionary treatment for Demodex blepharitis linked to dry eyes.